Comparative genomics and full-length Tprk profiling of Treponema pallidum subsp. pallidum reinfection.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
04 2020
Historique:
received: 05 11 2019
accepted: 08 02 2020
revised: 16 04 2020
pubmed: 7 4 2020
medline: 2 7 2020
entrez: 7 4 2020
Statut: epublish

Résumé

Developing a vaccine against Treponema pallidum subspecies pallidum, the causative agent of syphilis, remains a public health priority. Syphilis vaccine design efforts have been complicated by lack of an in vitro T. pallidum culture system, prolific antigenic variation in outer membrane protein TprK, and lack of functional annotation for nearly half of the genes. Understanding the genetic basis of T. pallidum reinfection can provide insights into variation among strains that escape cross-protective immunity. Here, we present comparative genomic sequencing and deep, full-length tprK profiling of two T. pallidum isolates from blood from the same patient that were collected six years apart. Notably, this patient was diagnosed with syphilis four times, with two of these episodes meeting the definition of neurosyphilis, during this interval. Outside of the highly variable tprK gene, we identified 14 coding changes in 13 genes. Nine of these genes putatively localized to the periplasmic or outer membrane spaces, consistent with a potential role in serological immunoevasion. Using a newly developed full-length tprK deep sequencing protocol, we profiled the diversity of this gene that far outpaces the rest of the genome. Intriguingly, we found that the reinfecting isolate demonstrated less diversity across each tprK variable region compared to the isolate from the first infection. Notably, the two isolates did not share any full-length TprK sequences. Our results are consistent with an immunodominant-evasion model in which the diversity of TprK explains the ability of T. pallidum to successfully reinfect individuals, even when they have been infected with the organism multiple times.

Identifiants

pubmed: 32251462
doi: 10.1371/journal.pntd.0007921
pii: PNTD-D-19-01868
pmc: PMC7162541
doi:

Substances chimiques

Bacterial Outer Membrane Proteins 0
Tpr protein, Treponema 0

Types de publication

Case Reports Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0007921

Subventions

Organisme : NIAID NIH HHS
ID : U19 AI144133
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Infect Immun. 2000 Nov;68(11):6482-6
pubmed: 11035764
PLoS Negl Trop Dis. 2015 Mar 20;9(3):e0003662
pubmed: 25793702
PLoS Negl Trop Dis. 2019 Jul 22;13(7):e0007621
pubmed: 31329597
J Clin Microbiol. 2006 Mar;44(3):888-91
pubmed: 16517872
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
mBio. 2015 May 05;6(3):e00519-15
pubmed: 25944861
Curr Top Microbiol Immunol. 2018;415:1-38
pubmed: 28849315
Infect Immun. 2006 Nov;74(11):6244-51
pubmed: 16923793
Bioinformatics. 2012 Jun 15;28(12):1647-9
pubmed: 22543367
J Infect Dis. 2010 Nov 1;202(9):1380-8
pubmed: 20868271
Microb Cell. 2016 Jun 27;3(9):363-370
pubmed: 28357375
LGBT Health. 2017 Jun;4(3):232-236
pubmed: 27991843
MMWR Morb Mortal Wkly Rep. 2014 May 9;63(18):402-6
pubmed: 24807239
mBio. 2018 Jun 26;9(3):
pubmed: 29946052
Infect Immun. 2006 Mar;74(3):1896-906
pubmed: 16495565
PLoS Negl Trop Dis. 2019 Feb 21;13(2):e0006855
pubmed: 30789907
Infect Immun. 2000 Feb;68(2):824-31
pubmed: 10639452
Clin Infect Dis. 2019 Sep 27;:
pubmed: 31560366
Nucleic Acids Res. 2019 Oct 10;47(18):e104
pubmed: 31418021
Mol Microbiol. 2011 Jun;80(6):1496-515
pubmed: 21488980
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
J Bacteriol. 2012 Aug;194(16):4208-25
pubmed: 22661689
Infect Immun. 2003 Oct;71(10):6054-7
pubmed: 14500529
J Infect Dis. 2019 Sep 09;:
pubmed: 31495889
Infect Immun. 2008 May;76(5):1848-57
pubmed: 18332212
Microbiol Spectr. 2014 Dec;2(6):
pubmed: 26104445
Rev Saude Publica. 2017 Jun 26;51:64
pubmed: 28678903
Front Microbiol. 2019 Jul 31;10:1691
pubmed: 31417509
J Immunol. 2010 Apr 1;184(7):3822-9
pubmed: 20190145
Nat Biotechnol. 2019 Oct;37(10):1155-1162
pubmed: 31406327
Nat Microbiol. 2016 Oct 17;2:16190
pubmed: 27748767
J Bacteriol. 2015 Jun;197(11):1906-20
pubmed: 25825429
mBio. 2018 Jun 12;9(3):
pubmed: 29895642
Infect Immun. 2010 Dec;78(12):5178-94
pubmed: 20876295
J Exp Med. 1999 Feb 15;189(4):647-56
pubmed: 9989979
J Infect Dis. 2000 Apr;181(4):1401-13
pubmed: 10762571
PLoS Negl Trop Dis. 2019 Jun 19;13(6):e0007463
pubmed: 31216284
Infect Immun. 2003 Oct;71(10):5605-12
pubmed: 14500480
Vaccine. 2014 Mar 20;32(14):1602-9
pubmed: 24135571
J Bacteriol. 2003 Nov;185(21):6262-8
pubmed: 14563860
Nat Commun. 2019 Jul 22;10(1):3255
pubmed: 31332179
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Nat Rev Microbiol. 2016 Dec;14(12):744-759
pubmed: 27721440
mSphere. 2019 Oct 2;4(5):
pubmed: 31578246
Nat Microbiol. 2016 Dec 05;2:16245
pubmed: 27918528
Am J Public Health. 2012 Jan;102(1):e1-8
pubmed: 22095364
Genomics Proteomics Bioinformatics. 2015 Oct;13(5):278-89
pubmed: 26542840
Microbes Infect. 2004 Jul;6(8):725-37
pubmed: 15207819
Mol Biol Evol. 2009 Jul;26(7):1641-50
pubmed: 19377059

Auteurs

Amin Addetia (A)

Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America.

Lauren C Tantalo (LC)

Department of Neurology, University of Washington, Seattle, Washington, United States of America.

Michelle J Lin (MJ)

Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America.

Hong Xie (H)

Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America.

Meei-Li Huang (ML)

Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America.

Christina M Marra (CM)

Department of Neurology, University of Washington, Seattle, Washington, United States of America.

Alexander L Greninger (AL)

Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH